Eli Lilly and CompanyLLYNYSE
LOADING
|||
Revenue Scaling
Trending higher, above historical average, modest growth trend.
Left:
||||
Total revenue from sales of goods and services
Latest
$45.04B
↑ 70% above average
Average (9y)
$26.55B
Historical baseline
Range
High:$45.04B
Low:$19.96B
CAGR
+9.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $45.04B | +32.0% |
| 2023 | $34.12B | +19.6% |
| 2022 | $28.54B | +0.8% |
| 2021 | $28.32B | +15.4% |
| 2020 | $24.54B | +9.9% |
| 2019 | $22.32B | +3.8% |
| 2018 | $21.49B | +7.6% |
| 2017 | $19.97B | -5.9% |
| 2016 | $21.22B | +6.3% |
| 2015 | $19.96B | - |